Literature DB >> 20427950

Pathophysiology of AKI: injury and normal and abnormal repair.

Joseph V Bonventre1.   

Abstract

The pathophysiology of acute kidney injury involves a complex interplay among vascular, tubular, and inflammatory factors followed by a repair process that can either restore epithelial differentiation and function to normal or result in progressive fibrotic chronic kidney disease. Innate and acquired immunity play an important role in the injury phase, in the regulation of the inflammatory response, and in processes related to repair of the epithelial layer. Recent data change the direction of focus of the role of the epithelium in fibrosis and attributes myelofibroblast production to perivascular and interstitial fibroblasts. The epithelium plays an important role in abnormal repair through a recently defined link between cell cycle arrest of the epithelial cell and profibrogenic cytokine production. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427950     DOI: 10.1159/000313738

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  51 in total

Review 1.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

2.  PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis.

Authors:  Rongpei Lan; Hui Geng; Aaron J Polichnowski; Prajjal K Singha; Pothana Saikumar; Donald G McEwen; Karen A Griffin; Robert Koesters; Joel M Weinberg; Anil K Bidani; Wilhelm Kriz; Manjeri A Venkatachalam
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

3.  Association between peritransplant kidney injury biomarkers and 1-year allograft outcomes.

Authors:  Isaac E Hall; Mona D Doshi; Peter P Reese; Richard J Marcus; Heather Thiessen-Philbrook; Chirag R Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-21       Impact factor: 8.237

4.  Urinary ATP Synthase Subunit β Is a Novel Biomarker of Renal Mitochondrial Dysfunction in Acute Kidney Injury.

Authors:  Ryan M Whitaker; Midhun C Korrapati; Lindsey J Stallons; Sean R Jesinkey; John M Arthur; Craig C Beeson; Zhi Zhong; Rick G Schnellmann
Journal:  Toxicol Sci       Date:  2015-02-09       Impact factor: 4.849

5.  Renoprotective mechanisms of ischemic postconditioning in ischemia-reperfusion injury: improved mitochondrial function and integrity.

Authors:  Hamid Moradi; Ping H Wang
Journal:  Nephrol Dial Transplant       Date:  2013-11       Impact factor: 5.992

Review 6.  Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

Authors:  Manjeri A Venkatachalam; Joel M Weinberg; Wilhelm Kriz; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2015-03-25       Impact factor: 10.121

Review 7.  Linking acute kidney injury to chronic kidney disease: the missing links.

Authors:  Mohammed A Kaballo; Mohamed E Elsayed; Austin G Stack
Journal:  J Nephrol       Date:  2016-12-07       Impact factor: 3.902

8.  P53 inhibitor pifithrin-α prevents the renal tubular epithelial cells against injury.

Authors:  Yun-Lin Shen; Lei Sun; Yu-Jie Hu; Hua-Jie Liu; Xin-Yu Kuang; Xiao-Ling Niu; Wen-Yan Huang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

9.  Transcription Factor Trps1 Promotes Tubular Cell Proliferation after Ischemia-Reperfusion Injury through cAMP-Specific 3',5'-Cyclic Phosphodiesterase 4D and AKT.

Authors:  Yang Ju-Rong; Chen Ke-Hong; Huang Kun; Fu Bi-Qiong; Lin Li-Rong; Zhang Jian-Guo; Li Kai-Long; He Ya-Ni
Journal:  J Am Soc Nephrol       Date:  2016-07-27       Impact factor: 10.121

Review 10.  Current developments in early diagnosis of acute kidney injury.

Authors:  Nicholas Obermüller; Helmut Geiger; Christine Weipert; Anja Urbschat
Journal:  Int Urol Nephrol       Date:  2013-05-15       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.